Jul 2, 2026 · 7 min
Semiconductors slide on Anthropic chip reports as Tesla slips
Semiconductor Stocks Fall, Tesla Sinks, Moderna Gains
As tech giants bring chip design in-house and auto leaders face valuation pressure, market leadership is rotating toward defensive sectors.
- 1Reports of Anthropic developing its own AI hardware are pressuring established semiconductor stocks.
- 2Tesla shares fell despite the company beating its second-quarter delivery expectations.
- 3Investors are rotating capital out of volatile tech names and into defensive pharmaceutical stocks like Moderna.
The brief
The semiconductor sector is facing fresh volatility as reports emerge that Anthropic is developing its own AI chip, a move that could disrupt the competitive balance and challenge dominant hardware players.
Despite beating second-quarter delivery expectations, Tesla saw its stock decline, signaling that strong volume metrics are no longer enough to satisfy demanding market expectations.
Amid tech sector turbulence, investors are rotating capital into defensive assets, sparking a notable upward trend for pharmaceutical companies like Moderna.
What was said on this episode
7 statements · 5 positive · 1 negative · 1 neutral
Anthropic is beginning early-stage work on its own AI chip and may partner with Samsung Electronics.
“the information was actually reporting about Anthropic and how they're starting early stage work on its own AI chip potentially holding stocks with Samsung Electronics about a potential manufacturing partner there”
Listen at 1:26
SanDisk had its best quarter on record in the second quarter.
“the second quarter was its best quarter on record”
Listen at 1:45
Chip stocks had their strongest first-half performance relative to the S&P 500 in history.
“the first half for chip stocks was the best first half relative to the S&P 500 in history”
Listen at 1:48
Tesla’s decline may reflect a buy-the-rumor, sell-the-news event.
“that stock was up for four consecutive straight sessions leading into this. So potentially being kind of buy the rumor, sell the news event.”
Listen at 3:34
Rivian raised its full-year sales guidance, making it a brighter spot.
“It also raised its full year guidance in sales outlook. So you're seeing a bit of a brighter spot for Rivian”
Listen at 3:52
Moderna announced positive vaccine developments.
“it announced some positive developments when it comes to vaccines and MRNA”
Listen at 4:34
Moderna’s stock rose 30% in the week after its science day.
“that stock's actually up 30% over the last week since that science day”
Listen at 4:38
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Tesla, Inc.
NASDAQ-100Listen to the full episode and explore every guest, topic, and moment on PodLume.